Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: From an older Filing...Very Interesting...

Dec 19, 2006 09:09AM

Dec 19, 2006 09:17AM

Dec 19, 2006 09:19AM

Dec 19, 2006 09:37AM
Well, and now take the number of OS in the first Dutton Report = 400mio outstanding shares and you could think that Pohl defines this as a target for the buyback. Fully diluted 42Xmio minus buyback equals 400mio OS. Just an idea...
Share
New Message
Please login to post a reply